Revelation Biosciences (REVB) Projected to Post Earnings on Friday

Revelation Biosciences (NASDAQ:REVB) is expected to be posting its quarterly earnings results before the market opens on Friday, March 28th. Analysts expect the company to announce earnings of ($3.20) per share for the quarter.

Revelation Biosciences Stock Performance

Shares of Revelation Biosciences stock opened at $2.83 on Thursday. The firm has a 50-day moving average of $3.99 and a 200-day moving average of $8.70. Revelation Biosciences has a 52-week low of $2.36 and a 52-week high of $60.80. The stock has a market cap of $2.56 million, a PE ratio of -0.01 and a beta of 0.17.

About Revelation Biosciences

Revelation Biosciences, Inc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease.